Overview

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

Status:
Completed

Trial end date:
2015-08-01

Target enrollment:

Participant gender:

Summary

To study the effect of ECP with Uvadex® in conjunction with a standard myeloablative conditioning regimen on the incidence of acute and chronic GvHD in patients undergoing an allogeneic related or unrelated BMT or PBSC transplant, for treatment of hematologic or lymphoproliferative malignancies.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Kansas
University of Kansas Medical Center

Collaborator:

Mallinckrodt